DaVita (DVA) | Stock Overview & Key Data
DaVita Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $211.84 on June 12, 2026
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DaVita
DVA
|
10.01B Large-cap | 9.20% | 5.01% | 41.51% | 74.72% | 83.17% | 53.29% | 113.75% | 71.55% | 177.81% | 396.45% | 753.76% |
|
HCA Healthcare
HCA
|
106.00B Large-cap | 7.93% | -7.81% | -25.75% | -18.24% | -17.10% | 4.31% | 33.47% | 92.28% | 400.04% | 1,019.34% | 1,144.15% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | 9.88% | -8.92% | -18.33% | -9.23% | -10.20% | 6.26% | 122.70% | 164.92% | 543.08% | 581.20% | 489.27% |
|
Universal Health
UHS
|
11.07B Large-cap | 2.17% | -13.44% | -24.55% | -34.80% | -33.61% | -14.41% | -1.48% | -0.20% | 11.56% | 181.90% | 492.07% |
|
Ensign Group
ENSG
|
11.06B Large-cap | -3.65% | -15.17% | -28.05% | -14.90% | -13.35% | -1.24% | 57.98% | 79.14% | 733.07% | 1,721.59% | 3,525.49% |
|
Encompass Health
EHC
|
10.25B Large-cap | -1.73% | -6.83% | -2.04% | -7.65% | -6.59% | -16.09% | 55.92% | 60.05% | 221.72% | 399.85% | 545.89% |
Ownership & Short Interest
Calculate Your DaVita Investment Returns
Long-Term Investment Performance Analysis
DaVita stock price in Jul 2016 was $77.91, A $1,000.00 lump sum investment in DaVita made 9 years ago would be worth approximately $2,692.21 today, representing a strong return of 169.22%. This translates to an annualized return (CAGR) of 10.51%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is DVA's 52-week high and low?
- In the last 52 weeks, DaVita reached a high of $211.80 (on June 12, 2026) and a low of $101.00 (on January 14, 2026).
- What is the market cap and P/E ratio for DVA?
- Curious about DaVita's size and valuation? Its market capitalization stands at 10.01B. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.32, and the forward P/E (looking ahead) is 9.45.
- Does DVA pay dividends? If so, what's the yield?
- As for dividends, DaVita isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are DaVita's main competitors or similar companies to consider before investing?
When looking at DaVita, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities 4.31% 33.47% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 6.26% 122.70% Universal Health
UHS11.07B Healthcare Medical Care Facilities -14.41% -1.48% Ensign Group
ENSG11.06B Healthcare Medical Care Facilities -1.24% 57.98% Encompass Health
EHC10.25B Healthcare Medical Care Facilities -16.09% 55.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for DaVita Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of DaVita's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 64.85%, the Debt to Equity ratio from the most recent quarter is 1,111.35, and its Gross Profit Margin stands at 33.43%.
- What is the recent revenue and earnings growth for DVA?
- Looking at DaVita's growth, its revenue over the trailing twelve months (TTM) was $14B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.90%, and quarterly earnings saw a YoY growth of -9.70%.
- How much of DVA stock is held by insiders and institutions?
- Wondering who owns DaVita stock? Company insiders (like executives and directors) hold about 51.20% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 53.62%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.